• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌钙蛋白I突变所致肥厚型心肌病的心肌延迟钆增强心血管磁共振成像

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

作者信息

Moon J C, Mogensen J, Elliott P M, Smith G C, Elkington A G, Prasad S K, Pennell D J, McKenna W J

机构信息

Centre for Advanced Magnetic Resonance in Cardiology, Royal Brompton Hospital, London, UK.

出版信息

Heart. 2005 Aug;91(8):1036-40. doi: 10.1136/hrt.2004.041384.

DOI:10.1136/hrt.2004.041384
PMID:16020591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1769031/
Abstract

OBJECTIVE

To examine the influence of genotype on late gadolinium enhancement (LGE) and the potential of cardiovascular magnetic resonance (CMR) to detect preclinical hypertrophic cardiomyopathy.

DESIGN

Prospective, blinded cohort study of myocardial LGE in a genetically homogeneous population.

PATIENTS

30 patients with disease causing mutations in the recognised hypertrophic cardiomyopathy gene for cardiac troponin I (TNNI3): 15 with echocardiographically determined left ventricular hypertrophy (LVH+) and 15 without (LVH-).

MAIN OUTCOME MEASURES

CMR measures of regional left ventricular function, wall thickness, and mass, and the extent and distribution of LGE.

RESULTS

LGE was found in 12 (80%) LVH+ patients but with variable extent (mean 15%, range 3-48%). LGE was also found in two (13%) LVH- patients but the extent was limited (3.6%) and both patients were found to have an abnormal ECG and regional hypertrophy by cine CMR. The extent of LGE was positively associated with clinical markers of sudden death risk (21% with > or = 2 risk factors v 7% with < or = 1 risk factor, p = 0.02) and left ventricular mass (r = 0.56, p < 0.001) and was inversely associated with ejection fraction (r = -0.58, p < 0.001). Segmental analysis showed that as regional wall thickness increased, LGE was more prevalent (p < 0.0001) and more extensive (r = 0.98, p = 0.001).

CONCLUSION

In patients with disease causing mutations in TNNI3, focal fibrosis was not detected by LGE CMR before LVH and ECG abnormalities were present. Once LVH is present, LGE is common and the extent correlates with adverse clinical parameters. This suggests that focal fibrosis is closely linked to disease development.

摘要

目的

研究基因型对延迟钆增强(LGE)的影响以及心血管磁共振成像(CMR)检测临床前肥厚型心肌病的潜力。

设计

对基因同质人群的心肌LGE进行前瞻性、盲法队列研究。

患者

30例在公认的肥厚型心肌病基因心肌肌钙蛋白I(TNNI3)中存在致病突变的患者:15例经超声心动图测定有左心室肥厚(LVH+),15例无左心室肥厚(LVH-)。

主要观察指标

CMR测定的左心室局部功能、室壁厚度、质量以及LGE的范围和分布。

结果

12例(80%)LVH+患者发现有LGE,但范围各异(平均15%,范围3%-48%)。2例(13%)LVH-患者也发现有LGE,但范围有限(3.6%),且这2例患者经电影CMR检查均发现有异常心电图和局部肥厚。LGE的范围与猝死风险的临床指标呈正相关(≥2个危险因素者为21%,≤1个危险因素者为7%,p = 0.02),与左心室质量呈正相关(r = 0.56,p < 0.001),与射血分数呈负相关(r = -0.58,p < 0.001)。节段分析显示,随着局部室壁厚度增加,LGE更常见(p < 0.0001)且范围更广(r = 0.98,p = 0.001)。

结论

在TNNI3基因存在致病突变的患者中,在出现左心室肥厚和心电图异常之前,LGE CMR未检测到局灶性纤维化。一旦出现左心室肥厚,LGE很常见,且范围与不良临床参数相关。这表明局灶性纤维化与疾病发展密切相关。

相似文献

1
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.肌钙蛋白I突变所致肥厚型心肌病的心肌延迟钆增强心血管磁共振成像
Heart. 2005 Aug;91(8):1036-40. doi: 10.1136/hrt.2004.041384.
2
[Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].[钆延迟强化在肥厚型心肌病患者心血管磁共振成像中的临床意义]
Rev Esp Cardiol. 2007 Jan;60(1):15-23.
3
Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.肥厚型心肌病患者延迟钆增强心血管磁共振成像中心肌强化的范围与Q波相关。
J Cardiovasc Magn Reson. 2007;9(3):595-603. doi: 10.1080/10976640600945465.
4
Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.肥厚型心肌病中与对比增强心血管磁共振相关的变量:临床意义
J Card Fail. 2008 Jun;14(5):414-9. doi: 10.1016/j.cardfail.2008.02.006. Epub 2008 May 27.
5
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.应用对比增强心脏磁共振成像对不同形式左心室肥厚相关重塑中纤维化进行无创检测。
J Am Coll Cardiol. 2009 Jan 20;53(3):284-91. doi: 10.1016/j.jacc.2008.08.064.
6
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者对比增强磁共振成像延迟钆增强的特征及临床意义。
Circ Heart Fail. 2010 Jan;3(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.109.854026. Epub 2009 Oct 22.
7
Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.肥厚型心肌病伴危及生命的室性心律失常患者心血管磁共振延迟钆增强。
Kardiol Pol. 2009 Aug;67(8A):964-9.
8
Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.心脏磁共振成像检测到的未被识别的心肌瘢痕对出现冠状动脉疾病体征或症状患者无事件生存期的影响。
Circulation. 2006 Jun 13;113(23):2733-43. doi: 10.1161/CIRCULATIONAHA.105.570648. Epub 2006 Jun 5.
9
Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.慢性缺血性心脏病患者血运重建后的功能转归:一项评估透壁瘢痕范围、室壁厚度和围手术期坏死情况的定量延迟钆增强心脏磁共振成像研究
J Cardiovasc Magn Reson. 2007;9(5):815-21. doi: 10.1080/10976640701547335.
10
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.肥厚型心肌病中的基质金属蛋白酶与组织重塑
Am Heart J. 2008 Jul;156(1):85-91. doi: 10.1016/j.ahj.2008.01.035.

引用本文的文献

1
Troponin I - a comprehensive review of its function, structure, evolution, and role in muscle diseases.肌钙蛋白I——对其功能、结构、进化及在肌肉疾病中的作用的全面综述。
Anim Cells Syst (Seoul). 2025 Jul 28;29(1):446-468. doi: 10.1080/19768354.2025.2533821. eCollection 2025.
2
Cardiac magnetic resonance and genetics in pediatric heart failure patients with nonischemia: prognostic implications.非缺血性小儿心力衰竭患者的心脏磁共振成像与遗传学:预后意义
World J Pediatr. 2025 May 22. doi: 10.1007/s12519-025-00920-8.
3
A Case Report on Diagnostic Approach of a Complex Clinical Scenario: Differentiation Between Coronary Artery Disease and Apical Hypertrophic Cardiomyopathy as a Cause of Recurrent Debilitating Angina.复杂临床情况诊断方法的病例报告:冠状动脉疾病与肥厚型心肌病心尖部病变作为复发性劳力性心绞痛病因的鉴别诊断
Cureus. 2021 Apr 15;13(4):e14496. doi: 10.7759/cureus.14496.
4
A case report: Twin sisters with restrictive cardiomyopathy associated with rare mutations in the cardiac troponin I gene.病例报告:患限制型心肌病的双胞胎姐妹与心肌肌钙蛋白I基因罕见突变相关
J Cardiol Cases. 2020 Dec 1;23(4):154-157. doi: 10.1016/j.jccase.2020.10.017. eCollection 2021 Apr.
5
Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.肥厚型心肌病中心肌纤维化的进展:机制与临床意义。
Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):157-167. doi: 10.1093/ehjci/jey135.
6
The Role of Cardiovascular Magnetic Resonance in Sports Cardiology; Current Utility and Future Perspectives.心血管磁共振成像在运动心脏病学中的作用:当前应用与未来展望
Curr Treat Options Cardiovasc Med. 2018 Aug 31;20(10):86. doi: 10.1007/s11936-018-0679-y.
7
Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.小儿肥厚型心肌病的延迟心肌强化:与左心室功能、超声心动图及人口统计学参数的相关性
Pediatr Cardiol. 2017 Jun;38(5):1024-1031. doi: 10.1007/s00246-017-1612-y. Epub 2017 Apr 11.
8
Targeted Next-Generation Sequencing Reveals Hot Spots and Doubly Heterozygous Mutations in Chinese Patients with Familial Cardiomyopathy.靶向二代测序揭示中国家族性心肌病患者的热点突变和双重杂合突变
Biomed Res Int. 2015;2015:561819. doi: 10.1155/2015/561819. Epub 2015 Jun 24.
9
Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.南非限制性心肌病和局灶性心室肥厚患者的诊断差异以及两个TNNI3基因突变的鉴定,其中一个为新发现的突变,另一个为新发突变。
Cardiovasc J Afr. 2015 Mar-Apr;26(2):63-9. doi: 10.5830/CVJA-2015-019.
10
Cardiac MRI: a central prognostic tool in myocardial fibrosis.心脏 MRI:心肌纤维化的中心预后工具。
Nat Rev Cardiol. 2015 Jan;12(1):18-29. doi: 10.1038/nrcardio.2014.159. Epub 2014 Oct 28.

本文引用的文献

1
Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.748例肥厚型心肌病连续家系中心脏肌钙蛋白I突变的频率及临床表型
J Am Coll Cardiol. 2004 Dec 21;44(12):2315-25. doi: 10.1016/j.jacc.2004.05.088.
2
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.肥厚型心肌病中钆延迟强化心血管磁共振成像的组织学基础
J Am Coll Cardiol. 2004 Jun 16;43(12):2260-4. doi: 10.1016/j.jacc.2004.03.035.
3
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.醛固酮通过新型信号蛋白,是肥厚型心肌病遗传缺陷与心脏表型之间的基本分子桥梁。
Circulation. 2004 Mar 16;109(10):1284-91. doi: 10.1161/01.CIR.0000121426.43044.2B. Epub 2004 Mar 1.
4
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.美国心脏病学会/欧洲心脏病学会关于肥厚型心肌病的临床专家共识文件。美国心脏病学会基金会临床专家共识文件特别工作组及欧洲心脏病学会实践指南委员会的报告。
J Am Coll Cardiol. 2003 Nov 5;42(9):1687-713. doi: 10.1016/s0735-1097(03)00941-0.
5
Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy.荧光单链构象多态性分析和变性高效液相色谱分析与直接测序法在肥厚型心肌病突变筛查中的比较
J Med Genet. 2003 May;40(5):e59. doi: 10.1136/jmg.40.5.e59.
6
Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?钆增强磁共振成像在肥厚型心肌病中的应用:对心脏性猝死病理基础的活体成像?
J Am Coll Cardiol. 2003 May 7;41(9):1568-72. doi: 10.1016/s0735-1097(03)00190-6.
7
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.钆增强心血管磁共振在肥厚型心肌病临床风险评估中的应用
J Am Coll Cardiol. 2003 May 7;41(9):1561-7. doi: 10.1016/s0735-1097(03)00189-x.
8
Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.特发性限制性心肌病是心肌肌钙蛋白I突变临床表型的一部分。
J Clin Invest. 2003 Jan;111(2):209-16. doi: 10.1172/JCI16336.
9
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.无症状或症状轻微的肥厚型心肌病患者的心肌瘢痕形成。
J Am Coll Cardiol. 2002 Dec 18;40(12):2156-64. doi: 10.1016/s0735-1097(02)02602-5.
10
Modifier genes for hypertrophic cardiomyopathy.肥厚型心肌病的修饰基因。
Curr Opin Cardiol. 2002 May;17(3):242-52. doi: 10.1097/01.HCO.0000013803.40803.6A.